Order Article Reprints

Li W, Wilson GC, Bachmann M, Wang J, Mattarei A, Paradisi C, Edwards MJ, Szabo I, Gulbins E, Ahmad SA, et al. Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model. Cancers. 2022; 14(11):2618. https://doi.org/10.3390/cancers14112618

Li, Weiwei, Gregory C. Wilson, Magdalena Bachmann, Jiang Wang, Andrea Mattarei, Cristina Paradisi, Michael J. Edwards, Ildiko Szabo, Erich Gulbins, Syed A. Ahmad, and et al. 2022. "Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model" Cancers 14, no. 11: 2618. https://doi.org/10.3390/cancers14112618

Li, W., Wilson, G. C., Bachmann, M., Wang, J., Mattarei, A., Paradisi, C., Edwards, M. J., Szabo, I., Gulbins, E., Ahmad, S. A., & Patel, S. H. (2022). Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model. Cancers, 14(11), 2618. https://doi.org/10.3390/cancers14112618